MAIA Biotechnology Files 8-K

Ticker: MAIA · Form: 8-K · Filed: Mar 26, 2025 · CIK: 1878313

Sentiment: neutral

Topics: 8-K, regulatory-filing, pharmaceuticals

TL;DR

MAIA Bio filed an 8-K on 3/26/25, check for updates.

AI Summary

MAIA Biotechnology, Inc. filed an 8-K on March 26, 2025, reporting other events and financial statements. The company, incorporated in Delaware with its principal executive offices in Chicago, IL, operates in the Pharmaceutical Preparations industry.

Why It Matters

This filing indicates MAIA Biotechnology is providing updates on its corporate activities and financial status to the SEC.

Risk Assessment

Risk Level: low — This is a routine filing with no immediate financial or operational impact disclosed.

Key Numbers

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by MAIA Biotechnology, Inc. in this 8-K filing?

The filing indicates 'Other Events' as an item, but the specific details of these events are not provided in the excerpt.

What is the primary business of MAIA Biotechnology, Inc. according to the SIC code?

The Standard Industrial Classification code 2834 indicates that MAIA Biotechnology, Inc. is in the business of Pharmaceutical Preparations.

When was the earliest event reported in this Form 8-K?

The earliest event reported in this Form 8-K was on March 26, 2025.

Where are MAIA Biotechnology, Inc.'s principal executive offices located?

MAIA Biotechnology, Inc.'s principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.

What is the Commission File Number for MAIA Biotechnology, Inc.?

The Commission File Number for MAIA Biotechnology, Inc. is 001-41455.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 26, 2025 regarding MAIA Biotechnology, Inc. (MAIA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing